In context it has been a little tepid insofar as the $$$ effect on the few 100 shares of XON I purchased at $31.58 in early Feb. on hearing Bill miller's statement that he regards XON as the biotech stock of the decade[CNBC, AH, 2/7/2015]. But + 51% in less than 2 months is not too bad, I guess.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.